Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07116330

Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

Status
Recruiting
Phase
Study type
Observational
Enrollment
420 (estimated)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown. The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study. The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.

Detailed description

Cluster design: Participating sites start with vascular risk factor intervention - patients are then offered participation in an observational 1-year study. In addition, all patients at the sites are followed in registers and compared to historic controls. Follow-up in the register study will be at least 5, but probably 10 years (until significant difference in primary analysis - Kaplan Meier).

Conditions

Interventions

TypeNameDescription
OTHERVascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests)The vascular risk assessment is outlined below, there may be slight variations according to local routines. Overall, the screening should include: Family history of vascular disease Tests/examinations (order or obtain from medical records \[past 3 months\]) Weight Height Waist circumference 12-lead ECG Resting and standing blood pressure Total cholesterol HDL cholesterol LDL cholesterol HbA1c High sensitivity CRP Serum creatinine Urine albumin-to-creatinine ratio Medical history Atherosclerotic cardiovascular disease Atrial fibrillation Congestive heart failure Diabetes mellitus Hypertension Kidney disease Life-style risk factors (smoking, exercis

Timeline

Start date
2025-09-01
Primary completion
2027-12-01
Completion
2035-06-01
First posted
2025-08-11
Last updated
2026-03-03

Locations

3 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07116330. Inclusion in this directory is not an endorsement.